Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.78B |
| 2 |
Microsoft
MSFT
|
+$2.22B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.67B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.65B |
| 5 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.19B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.45B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$533M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$410M |
| 4 |
Stellantis
STLA
|
+$312M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.28% |
| 2 | Healthcare | 11.27% |
| 3 | Financials | 10.52% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LCW
1751
DELISTED
Learn CW Investment Corporation Class A Ordinary Shares
LCW
| $2.32M | ﹤0.01% |
220,973
| – | – |
|
1752
ABM Industries
ABM
$2.84B
| $2.32M | ﹤0.01% |
54,288
+19,895
| +58% | +$862K |
|
1753
monday.com
MNDY
$3.7B
| $2.32M | ﹤0.01% |
13,522
+12,861
| +1,946% | +$1.92M |
|
1754
Leslie's
LESL
$14.2M
| $2.31M | ﹤0.01% |
12,320
+10,355
| +527% | +$2.14M |
|
1755
Southern Copper
SCCO
$161B
| $2.31M | ﹤0.01% |
34,784
+5,336
| +18% | +$364K |
|
1756
Calumet Specialty Products
CLMT
$3.65B
| $2.31M | ﹤0.01% |
145,500
+106,470
| +273% | +$1.75M |
|
1757
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.51B
| $2.31M | ﹤0.01% |
50,149
-68,544
| -58% | -$3.12M |
|
1758
CALL
American International
AIG
$42.4B
| $2.3M | ﹤0.01% |
+40,000
| New | +$2.15M |
|
|
TERN
1759
DELISTED
Terns Pharmaceuticals
TERN
| $2.3M | ﹤0.01% |
262,918
-271,842
| -51% | -$3.17M |
|
1760
Gates Industrial Corporation Ltd.
GTES
$7.24B
| $2.3M | ﹤0.01% |
170,313
+153,465
| +911% | +$1.99M |
|
1761
Kiniksa Pharmaceuticals
KNSA
$5.97B
| $2.29M | ﹤0.01% |
162,658
+479
| +0.3% | +$6.41K |
|
|
RPT
1762
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $2.29M | ﹤0.01% |
218,868
-5,483
| -2% | -$51.9K |
|
|
WIRE
1763
DELISTED
Encore Wire Corp
WIRE
| $2.29M | ﹤0.01% |
12,291
+991
| +9% | +$168K |
|
1764
Talos Energy
TALO
$2.35B
| $2.28M | ﹤0.01% |
164,635
+68,096
| +71% | +$917K |
|
1765
Milestone Pharmaceuticals
MIST
$147M
| $2.28M | ﹤0.01% |
800,776
-46,052
| -5% | -$174K |
|
|
TRTN
1766
DELISTED
Triton International Limited
TRTN
| $2.28M | ﹤0.01% |
27,410
-20,122
| -42% | -$1.63M |
|
1767
Fate Therapeutics
FATE
$290M
| $2.28M | ﹤0.01% |
479,099
-21,723
| -4% | -$120K |
|
1768
American States Water
AWR
$3.4B
| $2.28M | ﹤0.01% |
26,167
+6,704
| +34% | +$600K |
|
|
VERV
1769
DELISTED
Verve Therapeutics
VERV
| $2.27M | ﹤0.01% |
121,320
+12,474
| +11% | +$208K |
|
|
BCPC
1770
Balchem Corp
BCPC
$5.75B
| $2.27M | ﹤0.01% |
16,862
+692
| +4% | +$89K |
|
|
JHG
1771
DELISTED
Janus Henderson
JHG
| $2.27M | ﹤0.01% |
83,396
+56,650
| +212% | +$1.51M |
|
1772
Papa John's
PZZA
$811M
| $2.26M | ﹤0.01% |
30,667
-5,943
| -16% | -$441K |
|
1773
FB Financial Corp
FBK
$3.04B
| $2.26M | ﹤0.01% |
80,570
+20,096
| +33% | +$572K |
|
1774
Restaurant Brands International
QSR
$25.4B
| $2.26M | ﹤0.01% |
29,135
-16,628
| -36% | -$1.2M |
|
1775
Integra LifeSciences
IART
$1.33B
| $2.26M | ﹤0.01% |
54,848
+20,551
| +60% | +$989K |
|
Similar funds
Barclays's Q2 2023 Portfolio in Review
As of Q2 2023, Barclays held 5,371 positions worth $158B, down 28% from $218B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays withdrew a net $70.1B in Q2 2023, closing 872 positions and reducing 1,669 holdings. Its most notable exit was DCP Midstream, LP, an estimated $47.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR Nuveen ICE Municipal Bond ETF worth $36.9M.
- Barclays's largest Q2 2023 buy was State Street SPDR Nuveen ICE Municipal Bond ETF: 799,988 shares worth $36.9M.
- Barclays added most to Apple in Q2 2023, an estimated $2.78B increase.
- Barclays's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.45B.
- Barclays fully exited DCP Midstream, LP in Q2 2023, selling an estimated $47.3M.
- Barclays's ten largest holdings make up 24% of its $158B portfolio in Q2 2023.
- Barclays opened 314 new positions and closed 872 in Q2 2023.
- Barclays's portfolio value fell 28% quarter-over-quarter to $158B.
Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.